THIS INVENTION RELATES TO COMPOSITIONS DERIVED FROM CHINESE HERBAL MEDICINES, MEDICINAL PLANTS AND EXTRACTS THEREOF, AND TO THEIR USE FOR THE TREATMENT OF ANIMALS INFECTED WITH VIRUSES, ESPECIALLY WITH HEPATITIS B VIRUS (HBV), HEPATITIS C VIRUS (HCV), AND HUMAN IMMUNODEFICIENCY VIRUS (HIV). MORE SPECIFICALLY, THE COMPOSITIONS OF THE PRESENT INVENTION ARE DERIVED FROM VARIOUS CHINESE HERBAL MEDICINES OR MEDICINAL PLANTS WHICH HAVE A LONG HISTORY OF HUMAN CONSUMPTION. THE COMPOSITIONS OF THE INVENTION ARE OBTAINED THROUGH SPECIFIC TECHNIQUES AND HAVE DEMONSTRATED OUTSTANDING EFFICACY FOR TREATING HUMAN HBV CARRIERS AND HEPATITIS C PATIENTS. COMPOSITIONS ACCORDING TO THE INVENTION HAVE ALSO EXHIBITED IN VITRO ANTIVIRAL ACTIVITIES AGAINST MURINE LEUKEMIA VIRUS (MULV) AND HIV. HIV IS THE VIRUS KNOWN TO CAUSE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) IN HUMANS AND AIDS PRESENTS SPECIAL PROBLEMS TO THE MEDICAL COMMUNITY WHICH THE PRESENT INVENTION ADDRESSES.
